Skip to main content

Table 5 Odds ratios from multinomial logistic regression models for CKD stage 3 and stages 4–5 per μm increase in thickness of retinal layers supplied by the choroidal vasculature

From: Association of reduced inner retinal thicknesses with chronic kidney disease

ETDRS segmentRight eyeLeft eye
CKD stage 3 (vs. stage 1–2)CKD stage 4–5 (vs. stage 1–2)CKD stage 3 (vs. stage 1–2)CKD stage 4–5 (vs. stage 1–2)
OR95% CIpOR95% CIpOR95% CIpOR95% CIp
Outer plexiform layer
 N11.03(0.97, 1.10)0.331.03(0.96, 1.11)0.451.00(0.94, 1.07)0.891.00(0.93, 1.08)0.94
 S11.02(0.96, 1.09)0.460.95(0.86, 1.04)0.261.00(0.95, 1.06)0.930.93(0.87, 0.99)0.03*
 T11.07(0.96, 1.20)0.220.93(0.81, 1.08)0.341.11(1.02, 1.22)0.02*1.01(0.90, 1.13)0.84
 I11.01(0.94, 1.08)0.781.05(0.98, 1.14)0.181.04(0.97, 1.12)0.241.08(1.01, 1.16)0.03*
Outer nuclear layer
 N10.98(0.94, 1.01)0.220.95(0.91, 1.00)0.05*0.99(0.96, 1.02)0.350.97(0.93, 1.01)0.10
 S10.99(0.95, 1.03)0.520.97(0.92, 1.02)0.230.99(0.97, 1.02)0.450.99(0.96, 1.03)0.61
 T11.00(0.96, 1.04)0.891.00(0.97, 1.04)0.780.98(0.94, 1.01)0.200.98(0.95, 1.02)0.42
 I10.99(0.95, 1.03)0.680.96(0.91, 1.01)0.100.96(0.92, 1.00)0.070.94(0.89, 0.98)0.01*
Retinal pigmented epithelium
 N11.02(0.80, 1.30)0.881.00(0.75, 1.35)0.981.21(0.96, 1.53)0.111.01(0.76, 1.35)0.93
 S11.09(0.84, 1.42)0.510.97(0.70, 1.35)0.871.13(0.91, 1.39)0.260.77(0.55, 1.07)0.11
 T11.04(0.80, 1.35)0.791.05(0.76, 1.44)0.781.09(0.84, 1.41)0.531.01(0.74, 1.38)0.96
 I10.94(0.74, 1.20)0.631.00(0.75, 1.34)0.991.09(0.91, 1.31)0.340.99(0.77, 1.29)0.96
  1. ETDRS Early Treatment Diabetic Retinopathy Study, OR Odds ratio, SD Standard deviation, CI Confidence interval, F Fovea, S1 Superior segment 1, N1 Nasal segment 1, I1 Inferior segment 1, T1 Temporal segment 1.*significant values. Adjustment for age, mean arterial blood pressure, diabetes status, low-density lipoprotein, body mass index, and sex